扩散峰度成像直方图分析用于2016年WHO胶质瘤分级的在体评估:一项横断面观察性研究
该研究回顾性分析77例组织病理学确诊胶质瘤患者的DKI图像,由两名盲法医师独立测量肿瘤实质感兴趣区的MK和MD直方图参数。结果显示MK第25、50、75、90百分位数及平均MK在IDH1/2野生型胶质瘤、IDH1/2突变型胶质瘤和伴1p/19q杂合性缺失且IDH1/2突变的少突胶质细胞瘤间差异有统计学意义(p<0.001)。MK第50、75、90百分位数在按2016 CNS WHO整合诊断分级时诊断性能略高于平均MK。
要点
- MK直方图第50、75、90百分位数对2016 CNS WHO整合分级诊断性能最高,AUC范围0.868-0.991。
- 平均MK同样稳健可行,AUC范围0.855-0.988,适合日常临床实践。
- MK第25、50、75、90百分位数及平均MK在三类2016 CNS WHO整合诊断胶质瘤间差异有统计学意义(p<0.001)。
核心结论
- DKI直方图分析可按2016 CNS WHO整合诊断方法对胶质瘤进行分层,其中第50(中位数)、75和90百分位数诊断性能最高,平均MK同样稳健且可在常规临床实践中行。
研究设计与样本
- 横断面观察性研究,回顾性评估2014年1月至2017年3月来自一项经当地机构审查委员会批准的前瞻性试验的77例组织病理学确诊胶质瘤患者,由两名盲法医师独立测量整个肿瘤实质感兴趣区的MK和MD直方图参数。
诊断标准与关键数值
- MK第25、50、75、90百分位数及平均MK在IDH1/2野生型胶质瘤、IDH1/2突变型胶质瘤和伴1p/19q杂合性缺失且IDH1/2突变的少突胶质细胞瘤间差异有统计学意义(p<0.001)。
- MK第50、75、90百分位数按2016 CNS WHO整合诊断方法分类胶质瘤的AUC范围为0.868-0.991,略高于平均MK的AUC范围0.855-0.988。
临床应用与阅片要点
- 作者认为MK第50(中位数)、75和90百分位数诊断性能最高,平均MK同样稳健且可在常规临床实践中行。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To assess the diagnostic performance of histogram analysis of diffusion kurtosis imaging (DKI) maps for in vivo assessment of the 2016 World Health Organization Classification of Tumors of the Central Nervous System (2016 CNS WHO) integrated glioma grades.
MATERIALS AND METHODS: Seventy-seven patients with histopathologically-confirmed glioma who provided written informed consent were retrospectively assessed between 01/2014 and 03/2017 from a prospective trial approved by the local institutional review board. Ten histogram parameters of mean kurtosis (MK) and mean diffusivity (MD) metrics from DKI were independently assessed by two blinded physicians from a volume of interest around the entire solid tumor. One-way ANOVA was used to compare MK and MD histogram parameter values between 2016 CNS WHO-based tumor grades. Receiver operating characteristic analysis was performed on MK and MD histogram parameters for significant results.
RESULTS: The 25th, 50th, 75th, and 90th percentiles of MK and average MK showed significant differences between IDH1/2wild-type gliomas, IDH1/2mutated gliomas, and oligodendrogliomas with chromosome 1p/19q loss of heterozygosity and IDH1/2mutation (p<0.001). The 50th, 75th, and 90th percentiles showed a slightly higher diagnostic performance (area under the curve (AUC) range; 0.868-0.991) than average MK (AUC range; 0.855-0.988) in classifying glioma according to the integrated approach of 2016 CNS WHO.
CONCLUSIONS: Histogram analysis of DKI can stratify gliomas according to the integrated approach of 2016 CNS WHO. The 50th (median), 75th, and the 90th percentiles showed the highest diagnostic performance. However, the average MK is also robust and feasible in routine clinical practice.
引用
- Hempel JM, Schittenhelm J, Brendle C, et al. Histogram analysis of diffusion kurtosis imaging estimates for in vivo assessment of 2016 WHO glioma grades: A cross-sectional observational study. Eur J Radiol. 2017. PMID: 28987669. doi:10.1016/j.ejrad.2017.08.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。